Meng Lei
- Topics
- Ubiquitin and proteasome pathways (16 papers)Peptidase Inhibition and Analysis (12 papers)Multiple Myeloma Research and Treatments (5 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Meng Lei
26 papers receiving 439 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 219
- Oncology 149
- Organic Chemistry 141
- Biomaterials 78
- Biomedical Engineering 59
Countries citing papers authored by Meng Lei
This map shows the geographic impact of Meng Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Lei more than expected).
Fields of papers citing papers by Meng Lei
This network shows the impact of papers produced by Meng Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Lei. The network helps show where Meng Lei may publish in the future.
Co-authorship network of co-authors of Meng Lei
This figure shows the co-authorship network connecting the top 25 collaborators of Meng Lei. A scholar is included among the top collaborators of Meng Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Lei. Meng Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 7 | |
| 5 | 6 | |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 5 | |
| 9 | 34 | |
| 10 | 4 | |
| 11 | 6 | |
| 12 | 63 | |
| 13 | 68 | |
| 14 | 13 | |
| 15 | 10 | |
| 16 | 8 | |
| 17 | 36 | |
| 18 | 10 | |
| 19 | 11 | |
| 20 | 32 |
About Meng Lei
Meng Lei is a scholar working on Oncology, Hematology and Molecular Biology, having authored 26 papers that have together received 446 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (16 papers), Peptidase Inhibition and Analysis (12 papers) and Multiple Myeloma Research and Treatments (5 papers). The work is most often cited by research in Biomaterials (78 citations), Oncology (149 citations) and Pharmaceutical Science (31 citations). Meng Lei has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yongqiang Zhu, Xiao Du, Xueyuan Wang, Yanru Qin, Haoyang Zhang, Fengyi Zhao, Mengtao Ma, Mengyi Zhou, Fuliang Cao and Zhaogang Liu. Their work appears in journals such as Journal of Medicinal Chemistry, Carbohydrate Polymers and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.